Latest Breaking News On - Unyvero platform - Page 2 : comparemela.com

OpGen Announces Closing of $7 5 Million Public Offering

OpGen Announces Closing of $7 5 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMatthew bretziusOliver schachtCuretis gmbOpgen press contactTechnology platformOpgen incExchange commissionAlyssa factor edison groupSecurities exchangeGene panelHc wainwright coEuropean investment bankUnyvero platformAres genetics

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMatthew bretziusOliver schachtCuretis gmbOpgen press contactTechnology platformOpgen incEdison groupExchange commissionSecurities exchangeGene panelHc wainwright coEuropean investment bankUnyvero platformAres genetics

OpGen (OPGN) Prices 2 59M Share Offering at $2 90/sh

OpGen (OPGN) Prices 2 59M Share Offering at $2 90/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesExchange commissionOpgen incGene panelHc wainwright coUnyvero platformAres genetics

OpGen Announces Pricing of $7 5 Million Public Offering

ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power.

New yorkUnited statesMatthew bretziusOliver schachtCuretis gmbOpgen press contactTechnology platformOpgen incExchange commissionSecurities exchangeGene panelHc wainwright coEuropean investment bankUnyvero platformAres geneticsUnited statesa

OpGen, Inc : OpGen Announces Pricing of $7 5 Million Public Offering

ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) OpGen, Inc. (Nasdaq: OPGN, "OpGen" or "the Company"), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to

New yorkUnited statesMatthew bretziusOliver schachtCuretis gmbOpgen press contactTechnology platformOpgen incEdison groupExchange commissionSecurities exchangeGene panelHc wainwright coEuropean investment bankUnyvero platformAres genetics